Hamlet BioPharma AB (publ) 7ZT.F Stock
Hamlet BioPharma AB (publ) Price Chart
Hamlet BioPharma AB (publ) 7ZT.F Financial and Trading Overview
| Hamlet BioPharma AB (publ) stock price | 0.06 EUR |
| Previous Close | 0.21 EUR |
| Open | 0.22 EUR |
| Bid | 0.21 EUR x N/A |
| Ask | 0.25 EUR x N/A |
| Day's Range | 0.22 - 0.22 EUR |
| 52 Week Range | 0.2 - 0.39 EUR |
| Volume | 13K EUR |
| Avg. Volume | 232 EUR |
| Market Cap | 25.38M EUR |
| Beta (5Y Monthly) | 0.914942 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
7ZT.F Valuation Measures
| Enterprise Value | 23.87M EUR |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.2427746 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Hamlet BioPharma AB (publ) Stock Price History
| Beta (5Y Monthly) | 0.914942 |
| 52-Week Change | -35.47% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.39 EUR |
| 52 Week Low | 0.2 EUR |
| 50-Day Moving Average | 0.25 EUR |
| 200-Day Moving Average | 0.29 EUR |
7ZT.F Share Statistics
| Avg. Volume (3 month) | 232 EUR |
| Avg. Daily Volume (10-Days) | 0 EUR |
| Shares Outstanding | 73.57M |
| Float | 55.47M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | June 30, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -46.97% |
| Return on Equity (ttm) | -82.44% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | 9.96M EUR |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | N/A |
| Diluted EPS (ttm) | -0.02 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | N/A |
| Total Cash Per Share (mrq) | N/A |
| Total Debt (mrq) | N/A |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 6.358 |
| Book Value Per Share (mrq) | 0.173 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Hamlet BioPharma AB (publ)
| Country | Germany |
| State | N/A |
| City | Lund |
| Address | BMC D10 |
| ZIP | 222 42 |
| Phone | 46 40 12 25 00 |
| Website | https://www.hamletpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 5 |
Hamlet Pharma AB (publ), a pharmaceutical company, engages in the development of drugs for the treatment and prevention of cancer. It is developing HAMLET, a tumoricidal protein-lipid complex formed by two generally regarded as safe (GRAS) molecules found in human milk for various oncology markets, including colon, bladder, and cervix cancers, as well as primary or metastatic brain tumors. The company was incorporated in 1999 and is based in Lund, Sweden. Hamlet Pharma AB (publ) is a subsidiary of Linnane Pharma AB.
Q&A For Hamlet BioPharma AB (publ) Stock
What is a current 7ZT.F stock price?
Hamlet BioPharma AB (publ) 7ZT.F stock price today per share is 0.06 EUR.
How to purchase Hamlet BioPharma AB (publ) stock?
You can buy 7ZT.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Hamlet BioPharma AB (publ)?
The stock symbol or ticker of Hamlet BioPharma AB (publ) is 7ZT.F.
Which industry does the Hamlet BioPharma AB (publ) company belong to?
The Hamlet BioPharma AB (publ) industry is Biotechnology.
How many shares does Hamlet BioPharma AB (publ) have in circulation?
The max supply of Hamlet BioPharma AB (publ) shares is 218.4M.
What is Hamlet BioPharma AB (publ) Price to Earnings Ratio (PE Ratio)?
Hamlet BioPharma AB (publ) PE Ratio is 0.00000000 now.
What was Hamlet BioPharma AB (publ) earnings per share over the trailing 12 months (TTM)?
Hamlet BioPharma AB (publ) EPS is 0 EUR over the trailing 12 months.
Which sector does the Hamlet BioPharma AB (publ) company belong to?
The Hamlet BioPharma AB (publ) sector is Healthcare.